Despite challenges of decision making for unrepresented patients, few laws or policy statements offer solutions. This article offers 5 key things to do.
AMA J Ethics. 2019;21(7):E582-586. doi:
10.1001/amajethics.2019.582.
Physicians, committees, and guardians all make decisions for unrepresented patients in the US. This article considers a “tiered” approach as an alternative.
AMA J Ethics. 2019;21(7):E587-593. doi:
10.1001/amajethics.2019.587.
When patients are unable to express their wishes and do not have surrogates or advance directives, which and whose values should inform decision making for them? We discuss ethical complexities of caring for unrepresented patients.
Going to so-called safety-net clinics could mean being subject to different standards of care than those in other health care delivery settings. Learners who understand social determinants of health might be able to help patients navigate the system and access community resources.
AMA J Ethics. 2019;21(1):E44-49. doi:
10.1001/amajethics.2019.44.